▶ 調査レポート

網膜静脈閉塞症治療薬の世界市場（～2026年）
• 英文タイトル：Global Retinal Vein Occlusion Therapeutics Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。網膜静脈閉塞症治療薬の世界市場（～2026年） / Global Retinal Vein Occlusion Therapeutics Market Size, Status and Forecast 2020-2026 / MRC2-11QY04502資料のイメージです。• レポートコード：MRC2-11QY04502
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Multi User￥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料は網膜静脈閉塞症治療薬のグローバル市場について調査・分析したレポートです。種類別（網膜静脈分枝閉塞症、網膜中心静脈閉塞症）市場規模、用途別（病院、外来外科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別網膜静脈閉塞症治療薬の競争状況、市場シェア
・世界の網膜静脈閉塞症治療薬市場：種類別市場規模 2015年-2020年（網膜静脈分枝閉塞症、網膜中心静脈閉塞症）
・世界の網膜静脈閉塞症治療薬市場：種類別市場規模予測 2021年-2026年（網膜静脈分枝閉塞症、網膜中心静脈閉塞症）
・世界の網膜静脈閉塞症治療薬市場：用途別市場規模 2015年-2020年（病院、外来外科センター、その他）
・世界の網膜静脈閉塞症治療薬市場：用途別市場規模予測 2021年-2026年（病院、外来外科センター、その他）
・北米の網膜静脈閉塞症治療薬市場分析：米国、カナダ
・ヨーロッパの網膜静脈閉塞症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの網膜静脈閉塞症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の網膜静脈閉塞症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの網膜静脈閉塞症治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Sanofi Aventis、Bausch Health、Allergan
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization.
The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO).

Market Analysis and Insights: Global Retinal Vein Occlusion Therapeutics Market
The global Retinal Vein Occlusion Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Retinal Vein Occlusion Therapeutics Scope and Market Size
Retinal Vein Occlusion Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Vein Occlusion Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi Aventis
Bausch Health
Allergan
…

Market segment by Type, the product can be split into
Branch Retinal Vein Occlusion
Central Retinal Vein Occlusion
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Vein Occlusion Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Retinal Vein Occlusion Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Branch Retinal Vein Occlusion
1.4.3 Central Retinal Vein Occlusion
1.5 Market by Application
1.5.1 Global Retinal Vein Occlusion Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Retinal Vein Occlusion Therapeutics Market Perspective (2015-2026)
2.2 Global Retinal Vein Occlusion Therapeutics Growth Trends by Regions
2.2.1 Retinal Vein Occlusion Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Retinal Vein Occlusion Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Retinal Vein Occlusion Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Retinal Vein Occlusion Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Retinal Vein Occlusion Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Retinal Vein Occlusion Therapeutics Players by Market Size
3.1.1 Global Top Retinal Vein Occlusion Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Retinal Vein Occlusion Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Retinal Vein Occlusion Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinal Vein Occlusion Therapeutics Market Concentration Ratio
3.2.1 Global Retinal Vein Occlusion Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Retinal Vein Occlusion Therapeutics Revenue in 2019
3.3 Retinal Vein Occlusion Therapeutics Key Players Head office and Area Served
3.4 Key Players Retinal Vein Occlusion Therapeutics Product Solution and Service
3.5 Date of Enter into Retinal Vein Occlusion Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Retinal Vein Occlusion Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Retinal Vein Occlusion Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020)
5.2 Global Retinal Vein Occlusion Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Retinal Vein Occlusion Therapeutics Market Size (2015-2020)
6.2 Retinal Vein Occlusion Therapeutics Key Players in North America (2019-2020)
6.3 North America Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020)
6.4 North America Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Retinal Vein Occlusion Therapeutics Market Size (2015-2020)
7.2 Retinal Vein Occlusion Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020)
7.4 Europe Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Retinal Vein Occlusion Therapeutics Market Size (2015-2020)
8.2 Retinal Vein Occlusion Therapeutics Key Players in China (2019-2020)
8.3 China Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020)
8.4 China Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Retinal Vein Occlusion Therapeutics Market Size (2015-2020)
9.2 Retinal Vein Occlusion Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020)
9.4 Japan Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Retinal Vein Occlusion Therapeutics Market Size (2015-2020)
10.2 Retinal Vein Occlusion Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Retinal Vein Occlusion Therapeutics Market Size (2015-2020)
11.2 Retinal Vein Occlusion Therapeutics Key Players in India (2019-2020)
11.3 India Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020)
11.4 India Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Retinal Vein Occlusion Therapeutics Market Size (2015-2020)
12.2 Retinal Vein Occlusion Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi Aventis
13.1.1 Sanofi Aventis Company Details
13.1.2 Sanofi Aventis Business Overview
13.1.3 Sanofi Aventis Retinal Vein Occlusion Therapeutics Introduction
13.1.4 Sanofi Aventis Revenue in Retinal Vein Occlusion Therapeutics Business (2015-2020))
13.1.5 Sanofi Aventis Recent Development
13.2 Bausch Health
13.2.1 Bausch Health Company Details
13.2.2 Bausch Health Business Overview
13.2.3 Bausch Health Retinal Vein Occlusion Therapeutics Introduction
13.2.4 Bausch Health Revenue in Retinal Vein Occlusion Therapeutics Business (2015-2020)
13.2.5 Bausch Health Recent Development
13.3 Allergan
13.3.1 Allergan Company Details
13.3.2 Allergan Business Overview
13.3.3 Allergan Retinal Vein Occlusion Therapeutics Introduction
13.3.4 Allergan Revenue in Retinal Vein Occlusion Therapeutics Business (2015-2020)
13.3.5 Allergan Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Retinal Vein Occlusion Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Retinal Vein Occlusion Therapeutics Revenue
Table 3. Ranking of Global Top Retinal Vein Occlusion Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinal Vein Occlusion Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Branch Retinal Vein Occlusion
Table 6. Key Players of Central Retinal Vein Occlusion
Table 7. Global Retinal Vein Occlusion Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Retinal Vein Occlusion Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Retinal Vein Occlusion Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Retinal Vein Occlusion Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Retinal Vein Occlusion Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Retinal Vein Occlusion Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Retinal Vein Occlusion Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Retinal Vein Occlusion Therapeutics Players
Table 18. Global Retinal Vein Occlusion Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Retinal Vein Occlusion Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Retinal Vein Occlusion Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Vein Occlusion Therapeutics as of 2019)
Table 21. Global Retinal Vein Occlusion Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinal Vein Occlusion Therapeutics Product Solution and Service
Table 24. Date of Enter into Retinal Vein Occlusion Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Retinal Vein Occlusion Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Retinal Vein Occlusion Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Retinal Vein Occlusion Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Retinal Vein Occlusion Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Retinal Vein Occlusion Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Retinal Vein Occlusion Therapeutics Market Share (2019-2020)
Table 34. North America Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Retinal Vein Occlusion Therapeutics Market Share by Type (2015-2020)
Table 36. North America Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Retinal Vein Occlusion Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Retinal Vein Occlusion Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Retinal Vein Occlusion Therapeutics Market Share (2019-2020)
Table 40. Europe Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Retinal Vein Occlusion Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Retinal Vein Occlusion Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Retinal Vein Occlusion Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Retinal Vein Occlusion Therapeutics Market Share (2019-2020)
Table 46. China Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Retinal Vein Occlusion Therapeutics Market Share by Type (2015-2020)
Table 48. China Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Retinal Vein Occlusion Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Retinal Vein Occlusion Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Retinal Vein Occlusion Therapeutics Market Share (2019-2020)
Table 52. Japan Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Retinal Vein Occlusion Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Retinal Vein Occlusion Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Retinal Vein Occlusion Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Retinal Vein Occlusion Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Retinal Vein Occlusion Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Retinal Vein Occlusion Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Retinal Vein Occlusion Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Retinal Vein Occlusion Therapeutics Market Share (2019-2020)
Table 64. India Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Retinal Vein Occlusion Therapeutics Market Share by Type (2015-2020)
Table 66. India Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Retinal Vein Occlusion Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Retinal Vein Occlusion Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Retinal Vein Occlusion Therapeutics Market Share (2019-2020)
Table 70. Central & South America Retinal Vein Occlusion Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Retinal Vein Occlusion Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Retinal Vein Occlusion Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Retinal Vein Occlusion Therapeutics Market Share by Application (2015-2020)
Table 74. Sanofi Aventis Company Details
Table 75. Sanofi Aventis Business Overview
Table 76. Sanofi Aventis Product
Table 77. Sanofi Aventis Revenue in Retinal Vein Occlusion Therapeutics Business (2015-2020) (Million US$)
Table 78. Sanofi Aventis Recent Development
Table 79. Bausch Health Company Details
Table 80. Bausch Health Business Overview
Table 81. Bausch Health Product
Table 82. Bausch Health Revenue in Retinal Vein Occlusion Therapeutics Business (2015-2020) (Million US$)
Table 83. Bausch Health Recent Development
Table 84. Allergan Company Details
Table 85. Allergan Business Overview
Table 86. Allergan Product
Table 87. Allergan Revenue in Retinal Vein Occlusion Therapeutics Business (2015-2020) (Million US$)
Table 88. Allergan Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Vein Occlusion Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Branch Retinal Vein Occlusion Features
Figure 3. Central Retinal Vein Occlusion Features
Figure 4. Global Retinal Vein Occlusion Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Others Case Studies
Figure 8. Retinal Vein Occlusion Therapeutics Report Years Considered
Figure 9. Global Retinal Vein Occlusion Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Retinal Vein Occlusion Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Retinal Vein Occlusion Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Retinal Vein Occlusion Therapeutics Market Share by Players in 2019
Figure 14. Global Top Retinal Vein Occlusion Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Vein Occlusion Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Retinal Vein Occlusion Therapeutics Revenue in 2019
Figure 16. North America Retinal Vein Occlusion Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Retinal Vein Occlusion Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Retinal Vein Occlusion Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Retinal Vein Occlusion Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Retinal Vein Occlusion Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Retinal Vein Occlusion Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Retinal Vein Occlusion Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介
  • 網膜静脈閉塞症の世界市場（～2026年）
    Global Retinal Vein Occlusion Market Size, Status and Forecast 2020-2026
    MRC2-11QY04501 2020年11月20日 155Pages
    当調査資料は網膜静脈閉塞症のグローバル市場について調査・分析したレポートです。種類別（分枝網膜動脈閉塞症、網膜中心静脈閉塞症）市場規模、用途別（病院・診療所、研究・学術、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...
  • 静脈瘤治療の世界市場（～2026年）
    Global Varicose Vein Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04979 2020年11月20日 96Pages
    当調査資料は静脈瘤治療のグローバル市場について調査・分析したレポートです。種類別（アブレーション装置、高周波アブレーション装置、レーザーアブレーション装置、静脈閉鎖製品）市場規模、用途別（静脈内アブレーション、注射硬化療法、外科的結紮/剥離）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...
  • 深部静脈血栓症（DVT）治療薬の世界市場（～2026年）
    Global Deep Vein Thrombosis (DVT) Drug Market Size, Status and Forecast 2020-2026
    MRC2-11QY11584 2020年11月25日 97Pages
    当調査資料は深部静脈血栓症（DVT）治療薬のグローバル市場について調査・分析したレポートです。種類別（抗凝血剤、組織プラスミノーゲン活性化因子、その他薬剤）市場規模、用途別（病院、クリニック、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...
  • 網膜剥離の世界市場（～2026年）
    Global Retinal Detachment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04499 2020年11月20日 92Pages
    当調査資料は網膜剥離のグローバル市場について調査・分析したレポートです。種類別（網膜裂孔、網膜剥離、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、...
  • バルーン閉塞装置の世界市場（～2026年）
    Global Balloon Occlusion Device Market Insights and Forecast to 2026
    MRC2-11QY02935 2020年11月20日 111Pages
    当調査資料はバルーン閉塞装置のグローバル市場について調査・分析したレポートです。種類別（4mmタイプ、7mmタイプ）市場規模、用途別（頭蓋内手術、頸動脈治療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...
  • 網膜薬及び生物製剤の世界市場（～2026年）
    Global Retinal Drugs and Biologics Market Insights and Forecast to 2026
    MRC2-11QY09099 2020年11月25日 115Pages
    当調査資料は網膜薬及び生物製剤のグローバル市場について調査・分析したレポートです。種類別（加齢性黄斑変性症、糖尿病性網膜症、眼の炎症性疾患（ブドウ膜炎）、黄斑円孔）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...
  • 静脈血栓塞栓症（VTE）治療薬の世界市場（～2026年）
    Global Venous thromboembolism(VTE)Therapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY05000 2020年11月20日 90Pages
    当調査資料は静脈血栓塞栓症（VTE）治療薬のグローバル市場について調査・分析したレポートです。種類別（深部静脈血栓症（DVT）、肺塞栓症（PE）、その他）市場規模、用途別（病院、ASC、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...
  • 血友病A・B治療材料の世界市場（～2026年）
    Global Hemophillia A and B Therapeutics Materials Market Size, Status and Forecast 2020-2026
    MRC2-11QY12159 2020年11月25日 92Pages
    当調査資料は血友病A・B治療材料のグローバル市場について調査・分析したレポートです。種類別（デスモプレシン、オクトコガルファ、ノナコガルファ、その他）市場規模、用途別（歯科医院、病院、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、ア...
  • 血管内皮増殖因子Bの世界市場（～2026年）
    Global Vascular Endothelial Growth Factor B Market Insights and Forecast to 2026
    MRC2-11QY12961 2020年11月30日 117Pages
    当調査資料は血管内皮増殖因子Bのグローバル市場について調査・分析したレポートです。種類別（アフリベルセプト、アフリベルセプトバイオシミラー、CSL-346、その他）市場規模、用途別（直腸がん、網膜静脈閉塞症、糖尿病性腎症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...
  • 犬インフルエンザ治療薬の世界市場（～2026年）
    Global Canine Flu Therapeutics Market Size, Status and Forecast 2020-2026
    MRC2-11QY11240 2020年11月25日 96Pages
    当調査資料は犬インフルエンザ治療薬のグローバル市場について調査・分析したレポートです。種類別（ワクチン、その他）市場規模、用途別（獣医クリニック、獣医病院、動物医療施設）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...
  • 網膜静脈閉塞症の世界市場（～2026年）網膜静脈閉塞症の世界市場（～2026年） Retinal vein occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide. The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of patients, the presence of major market players, improvement in sur…
  • 静脈瘤治療の世界市場（～2026年）静脈瘤治療の世界市場（～2026年） Varicose Veins also referred to as varicosities are swollen, blue, twisted veins that appear on the skin. These are often seen near the legs. Market Analysis and Insights: Global Varicose Vein Treatment Market The global Varicose Vein Treatment market size is projected to reach US$ 401.9 million by …
  • 深部静脈血栓症（DVT）治療薬の世界市場（～2026年）深部静脈血栓症（DVT）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Deep Vein Thrombosis (DVT) Drug Market The global Deep Vein Thrombosis (DVT) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Deep Vein Thrombosis (DVT) Drug Scope and Market Si…
  • バルーン閉塞装置の世界市場（～2026年）バルーン閉塞装置の世界市場（～2026年） Balloon-occlusion devices cease flow in the ICA during the period of angioplasty and stenting.This device consists of a hypotube with a balloon on the end. After placement of the occlusion balloon distal to the carotid lesion, the lumen of the hypotube is used to inflate the balloon. Market Analysis…
  • 網膜剥離の世界市場（～2026年）網膜剥離の世界市場（～2026年） Retinal detachment occurs when the light-sensitive membrane (retina) in the back of the eye separates from its supporting layers. Most of the retinal detachments occurs due to retinal break, tear or hole. Retinal detachment can cause partial or total blindness, depending upon how much of the retina …